Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015)
Lineage Cell Therapeutics (LCTX) reported Inventory Average of $130500.0 for Q4 2015, down 49.77% on a YoY basis from $259783.5 in Q4 2014, and down 53.14% quarter-over-quarter from $278500.0 in Q3 2015.
Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015) Analysis & Trends
Lineage Cell Therapeutics has reported Inventory Average for 5 years, with the latest figure at $130500.0 in Q4 2015.
- For the quarter ending Q4 2015, Inventory Average fell 49.77% year-over-year to $130500.0; the trailing twelve-month figure through Dec 2015 stood at $130500.0 (down 49.77% YoY), and the FY2015 full-year result was $133500.0, down 39.96% from the prior year.
- Inventory Average for Q4 2015 stood at $130500.0, down from $278500.0 in the prior quarter.
- The five-year high for Inventory Average was $298154.0 in Q2 2015, with the low at $53020.0 in Q1 2012.
- Historically, Inventory Average has averaged $143926.5 across 5 years, with a median of $91425.8 in 2013.
- Annual changes were most pronounced in 2014 — Inventory Average jumped 322.38% — and 2015, when it plunged 49.77%.
- Lineage Cell Therapeutics' Inventory Average stood at $56144.5 in 2011, then declined by 0.0% to $56142.0 in 2012, then surged by 113.59% to $119913.0 in 2013, then surged by 116.64% to $259783.5 in 2014, then plunged by 49.77% to $130500.0 in 2015.
- The last three Inventory Average figures came in at $130500.0 (Q4 2015), $278500.0 (Q3 2015), and $298154.0 (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 130,500.00 |
| Sep 30, 2015 | 278,500.00 |
| Jun 30, 2015 | 298,154.00 |
| Mar 31, 2015 | 282,654.00 |
| Dec 31, 2014 | 259,783.50 |
| Sep 30, 2014 | 255,748.00 |
| Jun 30, 2014 | 247,258.50 |
| Mar 31, 2014 | 207,641.00 |
| Dec 31, 2013 | 119,913.00 |
| Sep 30, 2013 | 62,938.50 |
| Jun 30, 2013 | 58,540.00 |
| Mar 31, 2013 | 53,825.50 |
| Dec 31, 2012 | 56,142.00 |
| Sep 30, 2012 | 55,993.00 |
| Jun 30, 2012 | 54,942.00 |
| Mar 31, 2012 | 53,020.00 |
| Dec 31, 2011 | 56,144.50 |
| Sep 30, 2011 | 58,979.00 |